Morgan Stanley’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-354
Closed -$6.44K 8119
2024
Q2
$6.44K Sell
354
-334,078
-100% -$6.07M ﹤0.01% 6790
2024
Q1
$6.07M Sell
334,432
-203,656
-38% -$3.01M ﹤0.01% 3765
2023
Q4
$5.33M Buy
538,088
+400,603
+291% +$2.94M ﹤0.01% 4343
2023
Q3
$924K Sell
137,485
-5,542
-4% -$42.7K ﹤0.01% 4845
2023
Q2
$1.07M Sell
143,027
-2,501
-2% -$15.2K ﹤0.01% 4788
2023
Q1
$576K Sell
145,528
-3,425
-2% -$15.1K ﹤0.01% 5173
2022
Q4
$533K Sell
148,953
-11,599
-7% -$51.9K ﹤0.01% 5212
2022
Q3
$808K Sell
160,552
-15,100
-9% -$78K ﹤0.01% 5008
2022
Q2
$849K Buy
175,652
+16,300
+10% +$90K ﹤0.01% 5115
2022
Q1
$1.08M Sell
159,352
-30,645
-16% -$227K ﹤0.01% 4937
2021
Q4
$1.79M Buy
189,997
+37,376
+24% +$397K ﹤0.01% 4669
2021
Q3
$1.79M Sell
152,621
-5,386
-3% -$78K ﹤0.01% 4655
2021
Q2
$3.04M Sell
158,007
-3,604
-2% -$77.1K ﹤0.01% 4278
2021
Q1
$3.52M Sell
161,611
-44,831
-22% -$1.2M ﹤0.01% 3772
2020
Q4
$5.85M Sell
206,442
-25,134
-11% -$689K ﹤0.01% 3087
2020
Q3
$7.27M Sell
231,576
-251,780
-52% -$8.16M ﹤0.01% 2339
2020
Q2
$15.3M Buy
483,356
+57,885
+14% +$1.69M ﹤0.01% 1612
2020
Q1
$10.5M Buy
425,471
+66,716
+19% +$1.96M ﹤0.01% 1728
2019
Q4
$12.8M Buy
358,755
+309,876
+634% +$9.26M ﹤0.01% 2128
2019
Q3
$1.34M Buy
48,879
+6,287
+15% +$180K ﹤0.01% 4109
2019
Q2
$1.03M Buy
42,592
+41,134
+2,821% +$1.02M ﹤0.01% 4205
2019
Q1
$33K Sell
1,458
-63
-4% -$1.65K ﹤0.01% 5841
2018
Q4
$38K Sell
1,521
-15,178
-91% -$398K ﹤0.01% 5834
2018
Q3
$446K Sell
16,699
-13,232
-44% -$398K ﹤0.01% 5062
2018
Q2
$909K Buy
+29,931
New +$822K ﹤0.01% 4687

Other funds holding MOR

Morgan Stanley's MOR Position: Q3 2024 in Review

Morgan Stanley sold out of MorphoSys AG American Depositary Shares (MOR) in Q3 2024, closing a stake of 354 shares — an estimated $6.44K sold.

Morgan Stanley first reported a position in MOR in Q2 2018 and held it in 25 quarters. The position peaked at $15.3M in Q2 2020. 9 funds tracked by Wall St. Rank hold MOR as of Q3 2024.

  • Morgan Stanley reported no remaining MorphoSys AG American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Morgan Stanley sold 354 MorphoSys AG American Depositary Shares shares in Q3 2024, an estimated $6.44K.
  • Morgan Stanley first reported a position in MorphoSys AG American Depositary Shares in Q2 2018 and held it in 25 quarters.
  • Morgan Stanley's MorphoSys AG American Depositary Shares position peaked at $15.3M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q3 2024.

Based on Morgan Stanley's 13F filing for Q3 2024, filed 14 Nov 2024.